Raymond James Financial Services Advisors’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $5.3M | Buy |
115,403
+3,370
| +3% | +$155K | 0.01% | 1189 |
|
|
2024
Q2 | $4.58M | Sell |
112,033
-7,551
| -6% | -$308K | 0.01% | 1216 |
|
|
2024
Q1 | $3.05M | Buy |
119,584
+32,973
| +38% | +$841K | ﹤0.01% | 1414 |
|
|
2023
Q4 | $784K | Buy |
86,611
+51,839
| +149% | +$469K | ﹤0.01% | 2118 |
|
|
2023
Q3 | $222K | Buy |
34,772
+8,700
| +33% | +$55.5K | ﹤0.01% | 2859 |
|
|
2023
Q2 | $289K | Sell |
26,072
-10,582
| -29% | -$117K | ﹤0.01% | 2677 |
|
|
2023
Q1 | $563K | Buy |
36,654
+20,951
| +133% | +$322K | ﹤0.01% | 2254 |
|
|
2022
Q4 | $348K | Buy |
+15,703
| New | +$348K | ﹤0.01% | 2484 |
|